Your browser doesn't support javascript.
loading
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.
Blixt, Lisa; Bogdanovic, Gordana; Buggert, Marcus; Gao, Yu; Hober, Sophia; Healy, Katie; Johansson, Hemming; Kjellander, Christian; Mravinacova, Sara; Muschiol, Sandra; Nilsson, Peter; Palma, Marzia; Pin, Elisa; Smith, C I Edvard; Stromberg, Olga; Sällberg Chen, Margaret; Zain, Rula; Hansson, Lotta; Österborg, Anders.
Afiliación
  • Blixt L; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Bogdanovic G; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Buggert M; Department of Microbiology, Karolinska University Hospital, Stockholm, Sweden.
  • Gao Y; Center for Infectious Medicine, Dept of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Hober S; Center for Infectious Medicine, Dept of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Healy K; Department of Protein Science, SciLifeLab and KTH Royal Institute of Technology, Stockholm, Sweden.
  • Johansson H; Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Kjellander C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Mravinacova S; Department of Internal Medicine, Capio St Göran Hospital, Stockholm, Sweden.
  • Muschiol S; Department of Protein Science, SciLifeLab and KTH Royal Institute of Technology, Stockholm, Sweden.
  • Nilsson P; Department of Microbiology, Karolinska University Hospital, Stockholm, Sweden.
  • Palma M; Department of Protein Science, SciLifeLab and KTH Royal Institute of Technology, Stockholm, Sweden.
  • Pin E; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Smith CIE; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Stromberg O; Department of Protein Science, SciLifeLab and KTH Royal Institute of Technology, Stockholm, Sweden.
  • Sällberg Chen M; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Zain R; Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden.
  • Hansson L; Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Österborg A; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Leukemia ; 36(2): 476-481, 2022 02.
Article en En | MEDLINE | ID: mdl-34564699

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos B / Linfocitos T / Leucemia Linfocítica Crónica de Células B / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos B / Linfocitos T / Leucemia Linfocítica Crónica de Células B / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido